Ascendis Pharma A/S (ASND)

Ascendis Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	258.7	392.16	444.77	446.27	584.52	598.11
Short-Term Investments	-	7.28	290.69	235.8	134.28	-
Cash & Short-Term Investments	258.7	399.44	735.46	682.06	718.8	598.11
Cash Growth	-39.99%	-45.69%	7.83%	-5.11%	20.18%	115.25%
Accounts Receivable	49.16	35.87	11.91	2.2	0.39	0.8
Other Receivables	31.52	19.9	13.72	20.99	6.96	4.61
Receivables	80.68	55.77	25.63	23.19	7.34	5.41
Inventory	251.2	208.93	130.67	75.41	-	-
Prepaid Expenses	36.74	38.58	31.72	25.23	13.99	7.65
Total Current Assets	627.32	702.72	923.47	805.89	740.13	611.17
Property, Plant & Equipment	104.04	110.63	129.1	126.05	108.11	45.07
Long-Term Investments	20.56	5.69	30.42	145.91	124.46	15.54
Goodwill	-	3.5	3.5	3.5	3.5	3.5
Other Intangible Assets	4.19	0.92	1.33	1.78	2.22	-
Other Long-Term Assets	2.19	2.13	1.92	1.81	1.38	1.46
Total Assets	758.3	825.59	1,090	1,085	979.79	676.73
Accounts Payable	99.53	94.57	101.03	59.42	21.9	27.77
Accrued Expenses	26.41	41.18	31.99	29.95	23.38	13.35
Current Portion of Long-Term Debt	438.79	11.23	11.63	-	-	-
Current Portion of Leases	14.8	14.17	13.79	7	6.86	5.9
Current Income Taxes Payable	1.09	2.3	5.49	0.2	0.3	0.12
Current Unearned Revenue	1.29	1.18	-	2.6	0.36	0.86
Other Current Liabilities	265.83	32.72	7.34	1.19	-	-
Total Current Liabilities	847.74	197.34	171.27	100.36	52.8	47.99
Long-Term Debt	137.95	534.25	387.56	-	-	-
Long-Term Leases	81.1	84.62	95.4	97.97	85.12	30.72
Long-Term Unearned Revenue	5	5.95	14.21	2.96	-	-
Long-Term Deferred Tax Liabilities	7.64	5.83	-	-	-	-
Other Long-Term Liabilities	-	143.3	157.95	-	3.16	0.91
Total Liabilities	1,079	971.28	826.39	201.29	141.08	79.62
Common Stock	7.82	7.75	7.68	7.65	7.22	6.44
Additional Paid-In Capital	2,145	2,123	2,113	2,108	1,729	1,122
Retained Earnings	-2,474	-2,277	-1,860	-1,236	-1,030	-611.32
Treasury Stock	-0.12	-0.15	-0.15	-0.02	-	-
Comprehensive Income & Other	0.8	0.72	3.45	3.78	133.03	79.9
Shareholders' Equity	-321.13	-145.7	263.35	883.64	838.71	597.11
Total Liabilities & Equity	758.3	825.59	1,090	1,085	979.79	676.73
Total Debt	672.64	644.27	508.38	104.96	91.98	36.62
Net Cash (Debt)	-413.94	-244.83	234.57	684.66	742.1	561.49
Net Cash Growth	-	-	-65.74%	-7.74%	32.17%	102.07%
Net Cash Per Share	-7.29	-4.35	4.18	12.50	14.66	12.07
Filing Date Shares Outstanding	57.35	56.61	56.04	56.78	53.75	47.99
Total Common Shares Outstanding	57.35	56.61	56.04	56.78	53.75	47.99
Working Capital	-220.41	505.38	752.2	705.53	687.33	563.18
Book Value Per Share	-5.60	-2.57	4.70	15.56	15.60	12.44
Tangible Book Value	-325.32	-150.12	258.52	878.36	832.99	593.62
Tangible Book Value Per Share	-5.67	-2.65	4.61	15.47	15.50	12.37
Machinery	-	38.86	36.15	25.77	19.8	11.98
Leasehold Improvements	-	19.38	20.13	18.07	8.54	4.29

Source: S&P Capital IQ. Standard template. Financial Sources.